Comparison Overview
Eurofins Clinical Trial Solutions

Eurofins Clinical Trial Solutions
N/A
Last Update: 20/03/2026
Complex innovative clinical trial designs require an integrated synergetic approach to assess novel drug compounds for safety and effectiveness which often span esoteric, regulated and safety outcomes in all phases of the drug development life cycle. The companies of Eu...

Roche
Grenzacherstrasse, Switzerland 🇨🇭 , 4070, CH
Last Update: 17/09/2026
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to ...
Compliance Ranges Comparison

Eurofins Clinical Trial Solutions







Roche






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Eurofins Clinical Trial Solutions in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Roche in 2026.
Incident History - Eurofins Clinical Trial Solutions (X = Date, Y = Severity)
Eurofins Clinical Trial Solutions cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Roche (X = Date, Y = Severity)
Roche cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Eurofins Clinical Trial Solutions

Roche
FAQ
Latest Global CVEs
Exim before 4.100.1 allows SMTP smuggling in which the received message does not match any sent message, and instead depends on crafted data sent after a rejection during DATA processing.
Exim before 4.100.1, when Proxy-Protocol is used with an attacker-controlled proxy, allows attackers to read certain uninitialized data from stack memory.
Exim before 4.100.1, when certain non-default TLS settings are used with GnuTLS, has a use-after-free.
Exim before 4.100.1, when Proxy-Protocol is used with an attacker-controlled proxy, has an out-of-bounds write.
Mistral Vibe before 2.25.5 contains a remote code execution vulnerability in the worktree creation process that executes git hooks before trust validation. Attackers can supply a repository with a crafted post-checkout hook that executes arbitrary shell commands with the privileges of the user running Vibe.
- https://github.com/mistralai/mistral-vibe
- https://github.com/mistralai/mistral-vibe/blob/19b5b74faa78d0816b8d4d4c7d7543fc3520678c/vibe/core/git/repo.py#L411-L431
- https://github.com/mistralai/mistral-vibe/commit/c069ffa1e12fb5f2487b489217c40ab97721d553
- https://github.com/mistralai/mistral-vibe/issues/996
- https://github.com/mistralai/mistral-vibe/releases/tag/v2.25.5
- https://www.vulncheck.com/advisories/mistral-vibe-before-2.25.5-remote-code-execution-via-git-post-checkout